Research Progress of Breast Tissue Marker Clips and Their Application in Neoadjuvant Therapy for Breast Cancer
Keywords:
Breast Tissue Marker Clips, Neoadjuvant Therapy, Breast Cancer, Review
Abstract
Currently, breast cancer being of rapidly increasing incidence rates and as the most commonly diagnosed malignant tumor in breast surgery, has attracted much attention. Neoadjuvant therapy (NAT) has been proved to be beneficial for reducing tumor size and breast-conserving surgery. As a new type of metal localization marker, breast tissue marker clips can be used to precisely locate tumor tissue and improve cure rates. This review focuses on the marker clips and their significance in the diagnosis and treatment of neoadjuvant therapy for breast cancer, hoping to provide more clinical bases for research and promote this technology.References
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68(6): 394–424.
[2] Zhang X, Dong X, Guan Y, et al. Research progress on epidemiological trend and risk factors of female breast cancer. Cancer Research on Prevention and Treatment 2021; 48(1): 87–92.
[3] Chen W, Zheng R. Incidence, mortality and survival analysis of breast cancer in China. Chinese Journal of Clinical Oncology 2015; 42(13): 668–674.
[4] Von Minckwitz G, Untch M, Blohmer J, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012; 23(15):374–375.
[5] Consensus statements and clinical practice for image-guided percutaneous placement of breast tissue marker clip (2020)]. Chinese Journal of Surgery 2020; (3): 165–169.
[6] Oh J, Nguyen G, Whitman G, et al. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 2007; 69 (11): S71–S72.
[7] Patel J, Jenkins S. A technique for marking oncological breast tissue specimens. Ann Med Surg 2016; 7: 7–8.
[8] Volleamere A, Kirwan C. National survey of breast cancer specimen orientation marking systems. Eur J Surg Oncol 2013; 39(3): 255–259.
[9] Zada MH, Gallimidi Z, Schlesingerlaufer M, et al. Biodegradable breast tissue marker clip. ACS Appl Bio Mater 2020; 3(11): 7439–7453.
[10] Yun Y, Hong H, Wang F, et al. Ultrasound-guided insertion of a mammary localization needle to remove tiny lumps and subarm lymph nodes from the breast (in Chinese). Inner Mongolia Medical Journal 2008; (3): 366.
[11] Boughey J, Ballman K, Le-Petross H, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (t0-t4, n1-n2) who receive neoadjuvant chemotherapy: Results from ACOSOG Z1071 (Alliance). Ann Surg 2016; 263(4): 802–807.
[12] Zheng Y, Luo J, Xie X, et al. Application of ultrasound-guided wire localization of lesions combining with body mark for non-palpable breast lesions in surgical excision. Chinese Journal of Medical Ultrasound (Electronic Edition) 2013; 10(4): 331–334.
[13] Liu H, Wei D, Zhong R, et al. High frequency ultrasound guided positioning needle localization and marking application value in the operation resection of breast nodules. Jiangxi Medical Journal 2014; 49(8): 665–668.
[14] Tang X, Lang R, Fu L. Pathological assessment after neoadjuvant chemotherapy in breast cancer. Chinese Journal of Breast Disease (Electronic Edition) 2018; 12(5): 257–262.
[15] Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 2014; 384(9938):164–172.
[16] Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30(8): 1194–1220.
[17] Yang W, Bu H. Expert panel consensus on pathological-diagnosis of breast cancer within neoadjuvant therapy. Chinese Journal of Pathology 2015; 44(4): 232–236.
[18] Fu J, Chen H, Yang J, et al. Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: A meta-analysis. PloS One 2014; 9(9): e105316.
[19] Boughey J, Suman V, Mittendorf E, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. Jama 2013; 310(14): 1455–1461.
[20] Hartmann S, Reimer T, Gerber B, et al. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol 2018; 44(9): 1307–1311.
[21] Rüland A, Hagemann F, Reinisch M, et al. Using a new marker clip system in breast cancer: Tumark Vision® Clip - Feasibility testing in everyday clinical practice. Breast Care 2018; 13(2): 116–120.
[22] Yen P, Dumas S, Albert A, et al. Post-vacuum-assisted stereotactic core biopsy clip displacement: A comparison between commercially available clips and surgical clip. Can Assoc Radiol J 2018; 69(1): 10–15.
[23] Rosen E, Vo T. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology 2001; 218(2): 510.
[24] Esserman L, Cura M, Dacosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics 2004; 24(1):147–156.
[25] Bourke A, Peter P, Jose C. The disappearing clip: An unusual complication in MRI biopsy. BMJ Case Rep 2014.
[2] Zhang X, Dong X, Guan Y, et al. Research progress on epidemiological trend and risk factors of female breast cancer. Cancer Research on Prevention and Treatment 2021; 48(1): 87–92.
[3] Chen W, Zheng R. Incidence, mortality and survival analysis of breast cancer in China. Chinese Journal of Clinical Oncology 2015; 42(13): 668–674.
[4] Von Minckwitz G, Untch M, Blohmer J, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012; 23(15):374–375.
[5] Consensus statements and clinical practice for image-guided percutaneous placement of breast tissue marker clip (2020)]. Chinese Journal of Surgery 2020; (3): 165–169.
[6] Oh J, Nguyen G, Whitman G, et al. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 2007; 69 (11): S71–S72.
[7] Patel J, Jenkins S. A technique for marking oncological breast tissue specimens. Ann Med Surg 2016; 7: 7–8.
[8] Volleamere A, Kirwan C. National survey of breast cancer specimen orientation marking systems. Eur J Surg Oncol 2013; 39(3): 255–259.
[9] Zada MH, Gallimidi Z, Schlesingerlaufer M, et al. Biodegradable breast tissue marker clip. ACS Appl Bio Mater 2020; 3(11): 7439–7453.
[10] Yun Y, Hong H, Wang F, et al. Ultrasound-guided insertion of a mammary localization needle to remove tiny lumps and subarm lymph nodes from the breast (in Chinese). Inner Mongolia Medical Journal 2008; (3): 366.
[11] Boughey J, Ballman K, Le-Petross H, et al. Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (t0-t4, n1-n2) who receive neoadjuvant chemotherapy: Results from ACOSOG Z1071 (Alliance). Ann Surg 2016; 263(4): 802–807.
[12] Zheng Y, Luo J, Xie X, et al. Application of ultrasound-guided wire localization of lesions combining with body mark for non-palpable breast lesions in surgical excision. Chinese Journal of Medical Ultrasound (Electronic Edition) 2013; 10(4): 331–334.
[13] Liu H, Wei D, Zhong R, et al. High frequency ultrasound guided positioning needle localization and marking application value in the operation resection of breast nodules. Jiangxi Medical Journal 2014; 49(8): 665–668.
[14] Tang X, Lang R, Fu L. Pathological assessment after neoadjuvant chemotherapy in breast cancer. Chinese Journal of Breast Disease (Electronic Edition) 2018; 12(5): 257–262.
[15] Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 2014; 384(9938):164–172.
[16] Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30(8): 1194–1220.
[17] Yang W, Bu H. Expert panel consensus on pathological-diagnosis of breast cancer within neoadjuvant therapy. Chinese Journal of Pathology 2015; 44(4): 232–236.
[18] Fu J, Chen H, Yang J, et al. Feasibility and accuracy of sentinel lymph node biopsy in clinically node-positive breast cancer after neoadjuvant chemotherapy: A meta-analysis. PloS One 2014; 9(9): e105316.
[19] Boughey J, Suman V, Mittendorf E, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. Jama 2013; 310(14): 1455–1461.
[20] Hartmann S, Reimer T, Gerber B, et al. Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy. Eur J Surg Oncol 2018; 44(9): 1307–1311.
[21] Rüland A, Hagemann F, Reinisch M, et al. Using a new marker clip system in breast cancer: Tumark Vision® Clip - Feasibility testing in everyday clinical practice. Breast Care 2018; 13(2): 116–120.
[22] Yen P, Dumas S, Albert A, et al. Post-vacuum-assisted stereotactic core biopsy clip displacement: A comparison between commercially available clips and surgical clip. Can Assoc Radiol J 2018; 69(1): 10–15.
[23] Rosen E, Vo T. Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology 2001; 218(2): 510.
[24] Esserman L, Cura M, Dacosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics 2004; 24(1):147–156.
[25] Bourke A, Peter P, Jose C. The disappearing clip: An unusual complication in MRI biopsy. BMJ Case Rep 2014.
Published
2022-11-07
Issue
Section
Original Research Article
Copyright (c) 2022 Shutong Wan, Ziyang Huang, Yue Yang, Lu Li
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors submitting to USP journals agree to publish their manuscript under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) where authors agree to allow third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, and that in the event of reuse or distribution, the terms of this license are made clear
Authors retain copyright of their work, with first publication rights (online and print) granted to Universe Scientific Publishing or the owner of the journal in question.
